These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9115953)

  • 1. Emerging concepts: angiotensin-converting enzyme inhibition in coronary artery disease.
    Mancini GB
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():609-12. PubMed ID: 9115953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease.
    Mancini GB
    Am J Med; 1998 Jul; 105(1A):40S-47S. PubMed ID: 9707267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ischemic effects of angiotensin-converting enzyme inhibitors: a future therapeutic perspective.
    Ambrosioni E; Bacchelli S; Esposti DD; Borghi C
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S3-9. PubMed ID: 11392476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial function and bradykinin in humans.
    Hornig B; Drexler H
    Drugs; 1997; 54 Suppl 5():42-7. PubMed ID: 9429844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
    Mombouli JV
    Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
    Weber MA
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do ACE inhibitors modulate atherosclerosis?
    Curzen NP; Fox KM
    Eur Heart J; 1997 Oct; 18(10):1530-5. PubMed ID: 9347263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current indications for ACE inhibitors and HOPE for the future.
    Burch S; Ou N
    Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease.
    Cheng JW; Ngo MN
    Ann Pharmacother; 1997 Dec; 31(12):1499-506. PubMed ID: 9416388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors.
    Brown NJ; Vaughan DE
    Circulation; 1998 Apr; 97(14):1411-20. PubMed ID: 9577953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Ferrari R; Ceconi C; Curello S; Pepi P; Mazzoletti A; Visioli O
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():639-47. PubMed ID: 9115958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective potential of angiotensin converting enzyme inhibitors.
    Gavras I; Gavras H
    Braz J Med Biol Res; 1996 Jun; 29(6):701-5. PubMed ID: 9070382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.